|
Guidance on Mandated Clinical Trial Registration
Posted on 04/25/2008
Vice Chancellor Peccei and Executive Associate Dean Alan Robinson have released guidelines alerting the UCLA research community about the required registration of clinical trials/studies on ClinicalTrials.gov.
>>
Click here to view the memo
Regental Policy on Research Funded by the Tobacco Industry
Posted on 04/15/2008
Vice Chancellor Peccei has released a memo outlining The Regents’ new policy on research funded by the tobacco industry.
>>
Click here to view the memo
Preliminary Guidance about new NIH Public Access Policy
Posted on 04/08/2008
Vice Chancellor Peccei, Vice Provost Atchison, and University Librarian Strong have released guidelines alerting the UCLA research community about a new NIH
policy affecting all investigators who receive NIH research support.
>> Click here to view the memo
>> Click here to see Webinar slide show
Memo on Cost
Sharing
Posted on 08/17/2007
Vice Chancellor
Peccei has released guidelines meant to remind the UCLA
research community of the nature of cost sharing and what is
entailed in meeting cost sharing obligations.
>>
Click here to view the memo
David Geffen School of Medicine Industry Relationship Guidelines, effective July 1, 2007
Posted on 07/13/2007
Dean Gerald Levey has released new guidelines for faculty, staff, and students regarding interactions and relationships with industry. The guidelines were approved by the School of Medicine Faculty Executive Committee in November 2006, and are effective July 1, 2007.
>>
Click here for a link to the website
Memo on Responsibility for Executing Research and Research-Related Documents
Posted on 07/06/2007
Vice Chancellor Peccei and Vice Provost Atchison have released a memo on responsibility for executing research and research-related documents with a link to a matrix which provides general guidance for determining which administrative offices have responsibility for executing agreements.
>>
Click here to view the memo
UCLA Task Force Report on Managing Potential Conflicts of Interests Arising from the Licensing of the Technology
Posted on 06/19/2007
VC Roberto Peccei has issued a memorandum regarding guidelines developed by a campus Task Force established to consider the issue of conflicts of interest related to licensing of technology developed by UCLA investigators.
>>
Click here to view the Task Force report
California
Form 700-U New Validation Feature
Posted on 05/11/2007
A validation feature has been
added to the California Form 700-U, “Statement of Economic
Interests for Principal Investigators.” The validation
version of the form will provide prompts to remind responders
to complete each of the required fields. Upon completion,
respondents will receive a message if a supplemental form must
also be completed. The validation version of the Form
700-U can be completed on-line. However, because of
State requirements the form must still be printed and signed
in ink prior to submission. This validation version of
Form 700-U is available on the Research Policy and Compliance
Forms page.
>>
Click here to view the Forms page
Updates to UCLA
Procedure 925.3 - A Memo from VC Roberto Peccei
Posted on 03/02/2007
VC Roberto
Peccei issued a memorandum advising of changes to UCLA
Procedure 925.3. Document excerpt: "UCLA Procedure
925.3 'Disclosing Financial Interests Relevant to Federally
Sponsored Contracts and Grants for Research' has been revised
in response to suggestions made after a recent not-for-cause
federal site visit..."
>>
Click here to view the memo
Guidance on
Immigration Visa Applications, Outside Legal Assistance, and
Internal Processing Recharges
Posted on 10/27/2006
On October 24, 2006, VC Roberto
Peccei issued a memo as guidance on the charging of
immigration visa application fees, outside legal assistance
fees, and visa processing recharges. This memo
supersedes a prior guidance document on this subject issued on
October 30, 2003
>>
Click here to view the memo
UCLA-RAND Joint IRB
Deferral Mechanism for Health and Health Services Research
Memo
Posted on 08/10/2006
Roberto Peccei, UCLA Vice
Chancellor for Research, and Michael Rich, Executive Vice
President of the RAND Corporation
announced a new mechanism for facilitating
Institutional Review Board (IRB) review of research that
falls within the scope of the September 2002 UCLA-RAND
Memorandum of Understanding (MOU) for Health Services Research
>>
Click here to view the document
PI-Initiated Industry
Funded Clinical Trials Indirect Cost Rate Increase, Effective
July 1, 2006
Posted on 07/12/2006
Last fall, Vice Chancellor for
Research Roberto Peccei advised of an increase in the indirect
cost rate for industry initiated and supported clinical trials
to 26% (of total direct costs.) Effective July 1, 2006,
the same rate of 26% will be applied to Principal
Investigator-initiated industry funded clinical trials.
Thus the indirect cost rate for all industry supported
clinical trials will be 26% (applied to total direct costs.)
>>
Click here to view the document
Export
Control Regulations - A Quick Guide
Posted on 07/06/2006
This Export Control Quick Guide
has been developed as a summary of the laws, regulations, and
issues to be considered with regards to export controls and
research in the University setting. U.S. export license
requirements and export control laws and regulations enforced
by the Department of Commerce, Department of State, and
Department of the Treasury serve various government
objectives, particularly protecting national security and
advancing U.S. foreign policy. Read this Quick Guide to learn
more about the ways in which UCLA complies with these
regulations.
>>
Click here to view the document
Memo From VC
Roberto Peccei Regarding the Effort Reporting System (ERS)
Posted on 06/16/2006
The Effort
Reporting System (ERS) is a newly developed, fully automated
system that will streamline the effort reporting process and
address issues that exist within the current Personnel
Activity Report (PAR) system. It will refine and correct
calculations, eliminate paper reporting, and provide
mechanisms to adequately monitor effort reporting and ensure
compliance with federal reporting requirements. More
information about ERS can be found at www.efm.ucla.edu/effortrpt.htm.
>>
Click here to view the document
UCLA/RAND
MOU Amendment
Posted on 06/16/2006
An amendment to the UCLA/RAND
Memorandum of Understanding (MOU) effective June 7, 2006
outlines the IRB review process for collaborative health
services research involving human research subjects.
>>
Click here to view the document
Creation
of UCLA Embryonic Stem Cell Research Oversight (ESCRO)
Committee
Posted on 05/03/2006
Vice
Chancellor for Research Roberto Peccei recently released a
memo announcing the creation of the human Embryonic Stem Cell
Research Oversight (ESCRO) committee as an initial step to
provide oversight of research involving human embryonic stem
cells (hESC). The establishment of the committee was
first announced in Vice Chancellor Peccei’s memo on Preliminary
Guidance on Conducting Human Embryonic Stem Cell Research at
UCLA which was
disseminated on August 2, 2005. The ESCRO will
help ensure that UCLA hESC research meets the highest
scientific, ethical, and legal standards while facilitating
the conduct of such research. The policies, procedures,
and forms for ESCRO review are at http://www.research.ucla.edu/researchpol/stemcelldocs.htm.
>>
Click
here to view the document
Non-Competitive
Funding Guidelines
Posted on 01/27/2006
The
University of California Guidelines on Non-Competitive Funding
has recently been released. These guidelines outline the
circumstances that warrant requests to seek
congressional-directed ("earmarked") research
funding. Click here to read Executive Vice Chancellor and
Provost Dan Neuman's memo, which provides UCLA's process for
reviewing and evaluating earmark funding requests and includes
relevant web links on the subject
>>
Click
here to view the document
UC HIPAA
Website Now Live
Posted on 08/19/2005
A new and improved UC
HIPAA website with Research Compliance links is now available.
The site includes guidelines for conducting research at the UC
in compliance with HIPAA requirements, FAQs and training
modules. A permanent link to this site has been added to
our "Other Compliance Resources" section as well.
>>
Click here to view the new UC HIPPAA site
Preliminary
Guidance on Conducting Human Embryonic Stem Cell Research at
UCLA
Posted on 08/05/2005
A memo regarding Preliminary Guidance
on Conducting Human Embryonic Stem Cell Research (hESC) at
UCLA was issued on August 2, 2005 by Roberto Peccei, Vice
Chancellor for Research and Alan Robinson, Associate Vice
Chancellor, Medical Sciences. It provides interim guidance to
the campus research community until UCOP and other campuses
develop consistent stem cell research policies compliant with
state and federal regulations
>>
Click here to see the memo
Updated
Conflict of Interest in Research Procedures
Updates were recently made to UCLA Procedures 925.2
"Disclosing Financial Interests in Non-Governmental
Sponsors of Contracts and Grants for Research" and
925.3 "Disclosing Financial Interests Related to
Government Sponsored Contracts and Grants for
Research" and became effective August 30, 2004. A
September 14, 2004 memo from VC Roberto Peccei highlighted
key changes, including the use of new financial disclosure
forms.
>> Click here to see the memo. |
Back to Top
home page